Conexeu Sciences Inc. (CNXU)
Conexeu Sciences will go public soon, but the exact IPO date is still unknown.
IPO Price
$10.00
Shares Offered
9,481,123
Deal Size
$94.81M
Company Description
Conexeu is a company focused on building a new class of collagen-based regenerative tissue products.
Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property developed over more than a decade at the University of British Columbia and the BC Professional Firefighters Burn and Wound Healing Laboratory.
The Company's only device candidate is the CXU™ scaffold device candidate. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications.
Conexeu Sciences Inc.
| Country | United States |
| Founded | 2022 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Miles Harrison |
Contact Details
Address: 50 West Liberty Street, Suite 880 Reno, NV 89501 United States | |
| Phone | 424-333-5622 |
| Website | conexeu.com |
Stock Details
| Ticker Symbol | CNXU |
| Exchange | NASDAQ |
| Fiscal Year | November - October |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 2066836 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Miles Harrison | President, Chief Executive Officer and Director |
| Stephen D. Inouye | Chief Financial Officer, Secretary and Treasurer |
| Dr. Brian K. Pilcher, PhD | Chief Medical Officer |
| Dr. Claudia Chavez-Munoz, PhD | Chief Science Officer |
| Jeff Sharpe | Non-executive Chairman and Director |
| Sebastian Purcell | Director |
| Aaron Farberg | Director |
| David Bogart | Director |
| Dr. Paul Lorenc | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 4, 2026 | D | Notice of Exempt Offering of Securities |
| Feb 3, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Nov 28, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Nov 20, 2025 | D | Notice of Exempt Offering of Securities |
| Nov 13, 2025 | D | Notice of Exempt Offering of Securities |
| Oct 14, 2025 | C-U | Filing |
| Sep 23, 2025 | C-U | Filing |
| Jul 30, 2025 | C/A | Filing |
| Jul 30, 2025 | C | Filing |
| Jul 2, 2025 | D/A | Filing |